On Friday, November 3, 2023, the U.S. District Court for the District of South Carolina issued a long-awaited decision in Genesis Health Care, Inc. v. Becerra—a case dating back to 2017 contesting HRSA’s definition of...more
Donald Trump extended two directives restricting the admission of certain immigrants and nonimmigrants to the U.S. Specifically, Presidential Proclamation (PP) 10014 restricting the admission of first-time immigrants and PP...more
1/6/2021
/ Advisory Opinions ,
Compliance ,
Covered Entities ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Enforcement Actions ,
Final Rules ,
Health Care Providers ,
Manufacturers ,
Medicaid ,
OGC ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Section 340B
We are back again with another 340B post. The 340B program has recently been a regular feature on the blog in the context of ongoing litigation discussed here and here. Today, we wanted to provide readers the details of an...more
9/24/2020
/ Covered Entities ,
Drug Pricing ,
GAO ,
HRSA ,
Manufacturers ,
Medicaid ,
New Guidance ,
OIG ,
Pharmaceutical Industry ,
Prescription Drugs ,
Section 340B